Partner
Mike Dybbs
Partner, Samsara BioCapital
- Firm
- Samsara BioCapital
- Title
- Partner
- Role
- Partner
- Known as
- Investor
Claim, correct or request removal
Record updated 4 October 2026
About
Mike Dybbs has been a Partner at Samsara since the fund was launched in 2017. He currently serves on the board of a number of Samsara portfolio companies, including: Kalaris (KLRS), Nkarta Therapeutics (NKTX), Sutro (STRO), and several private companies. Prior to Samsara, Mike was a Partner at New Leaf Venture Partners, where he served on the boards of Versartis (VSAR), Dimension Therapeutics (DMTX), Advanced Cell Diagnostics (acquired by Bio-Techne) and Principia (PRNB, acquired by Sanofi). Before joining New Leaf, Mike was a Principal at the Boston Consulting Group, where he was a core member of their health care practice.
Is this you? Remove my profile
Loading relationship preview